Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer

Background/Aim: Published data have shown that palbociclib-fulvestrant can significantly improve the progression-free survival (PFS) of estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) metastatic breast cancer patients, but not of Japanese patients. We conduct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: SEKI, HIROHITO, SAKURAI, TAKASHI, MAEDA, YUKA, OKI, NAOHIKO, AOYAMA, MINA, YAMAGUCHI, RYOU, TOKUDA, TOSHIKI, KABURAGI, TAKUJI, OKUMURA, TAKEHIRO, KARAHASHI, TSUYOSHI, NAKAJIMA, KENICHIRO, HIGETA, KAORI, SHIMIZU, KEN
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899113/
https://ncbi.nlm.nih.gov/pubmed/31662535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11701
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados